Sharemaestro company-news research for Stryker Corporation (SYK), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
VIE
Austria
Measured evidence
Company news sentiment
SYK news sentiment
Stryker Corporation
Company headlines compared by relevance, subject, source independence, tone and the market's completed price response.
Weighted tone71Neutral is 50
Constructive news tone
69/100 evidence confidence
100% direct company focus
5 current stories across 1 publishers
Current company news
News confirmed by price
Constructive news tone is drawn from 5 fresh independent stories, including 5 company-specific items across 1 publishers.
Latest source headline PBH or SYK: Which Is the Better Value Stock Right Now? finance.yahoo.com · 12 Aug 2026 15:40What supports the read
5 current stories are mapped specifically to SYK.
Cross-story agreement is 91/100, indicating a comparatively coherent tape.
Constructive news tone is being confirmed by positive weekly price action.
What tempers the read
Only 1 publisher currently contribute to the measured read.
71/100
Weighted toneConstructive news tone
69/100
Evidence confidencesolid confidence
100%/100
Company focus5 direct stories
91/100
Evidence agreement9/100 dispersion
News history
Tone and story flow over 21 days
24 Jul03 Aug13 Aug
Weighted toneStory volumeNeutral 50
Evidence confidence
What supports the score
Confidence rises through sample depth, independent publishers, direct company relevance, freshness and agreement. A high or low tone score is not itself evidence of reliability.
Sample depth55
4.39 effective storiesSource breadth20
1 independent publishersDirect relevance100
company-specific evidence shareFreshness75
recency-weighted evidenceAgreement91
cross-story consistencySource independence0
lower publisher concentrationPrice context
Sentiment against the 26-week price path
Constructive news tone is being confirmed by positive weekly price action.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
Sentiment-trend disagreement
News subjects
What is shaping the score
Earnings882 stories · 40%
Market update851 stories · 20%
Analyst action821 stories · 20%
Capital return641 stories · 20%
Source mix
Where the evidence comes from
finance.yahoo.com825 stories · 100%
Recurring subjects
Subjects appearing most often
Earnings4Medical Devices3Price Target2Value Investing1Tricuspid Valve1Tariffs1Surgical Robotics1Split1Share Price1Share Buyback1
Earlier readings
How the score has changed
ConstructiveBalanced or withheldCautious
Source headlines
The news behind the score
Every row shows the public evidence used to understand the read. Direct company stories carry more weight than industry or sector context; duplicate coverage is consolidated before scoring.
#189Tone
finance.yahoo.comDirect company coverage
PBH or SYK: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical - Products stocks have likely encountered both Prestige Consumer Healthcare (PBH) and Stryker (SYK). But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look. Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with a strong Zacks Rank. The Zacks Rank is a proven strategy that targets companies with positive earnings estimate revision trends, while our Style Scores work to grade
EarningsEarnings EstimateGrowth RateMedical ProductsShare PriceValue Investing
- Published
- 12 Aug 2026 15:40
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#286Tone
finance.yahoo.comDirect company coverage
Stryker’s (SYK) Comeback Quarter Looks Great, But At What Cost?
Stryker (NYSE:SYK) turned in one of its stronger quarters in recent memory on July 30, with sales climbing 9.4% to $6.6 billion and reported EPS jumping 44.1% to $3.30. The numbers arrive as the company works its way back from a cyber incident that had rattled its business, and CEO Kevin Lobo pointed to that recovery as proof of the company's resilience. But a closer look at how those earnings were adjusted tells a more complicated story about what is really driving the bottom line.Stryker's (SYK) Comeback Quarter Looks Great, But At What Cost? Bull Case: Growth That Touched Every Corner Of Th
EarningsEarnings Per ShareGuidanceMedical DevicesOperating Income
- Published
- 11 Aug 2026 21:23
- Catalyst
- Earnings
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#364Tone
finance.yahoo.comDirect company coverage
The Number One Reason I Keep Buying Intuitive Surgical Now For The Long Run
Quick Read ISRG is down 31% YTD, but its razor-and-razorblade model now delivers 85% recurring revenue across a fleet of 11,710 da Vinci systems. MDT's Hugo and JNJ's Ottava remain early or pre-commercial, leaving ISRG's $1.73 billion quarterly instruments-and-accessories stream with no real soft-tissue competition. The dV5 supercycle is early, with only 1,700 of nearly 13,000 total systems upgraded and over 100 platform updates still planned. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Intuitive Surgical didn't make the cut. Grab the names FREE today.
Balance SheetEarningsHealthcareShare BuybackSplitSurgical Robotics
- Published
- 11 Aug 2026 13:09
- Catalyst
- Capital return
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#485Tone
finance.yahoo.comDirect company coverage
Versa Vascular Appoints Bill Shields as Chief Executive Officer
Company Expands Series C Financing to $42M SANTA CRUZ, Calif., August 11, 2026--(BUSINESS WIRE)--Versa Vascular, Inc., a pioneering medical device company dedicated to transforming tricuspid valve disease treatment, announced the appointment of Bill Shields as Chief Executive Officer. Former Versa CEO David Hovda is retiring and will remain an advisor to the company. Shields spent the last 15 years with Medtronic's structural heart franchise, most recently as Vice President and General Manager of its Transcatheter Mitral and Tricuspid Therapies division, where he spent seven years leading prod
Clinical TrialsHeart DiseaseMedical DevicesSeries C FinancingTricuspid Valve
- Published
- 11 Aug 2026 12:00
- Catalyst
- Market update
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
#582Tone
finance.yahoo.comDirect company coverage
The Robotic Surgery Leader: Intuitive Surgical Slides Further But One Wall Street Bull Pegs Returns at 85%
Quick Read ISRG dropped 34% on a slower procedure growth guide, yet Q2 EPS of $2.80 crushed the $2.50 consensus for a fifth straight quarterly beat. ISRG trades 28% below Wall Street consensus while peers MDT and SYK fell less than 10% YTD, suggesting the market overcorrected on the category leader. Bernstein's $685 target implies 83% upside with the bull case hinging on the da Vinci 5 upgrade cycle mirroring the prior seven-year Xi ramp. Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Intuitive Surgical didn't make the cut. Grab the names FREE today. Intui
EarningsMedical DevicesPrice TargetPrice TargetRobotsTariffs
- Published
- 08 Aug 2026 11:05
- Catalyst
- Analyst action
- Evidence role
- Direct company coverage
- Duplicates
- 1 consolidated
Earlier company news
SYK news archive
Stored newest first for historical research. These older headlines are retained for reference and do not contribute to the current sentiment gauge above.
Aug
07
2026
MarketBeatArchivedNeutral tone
Stryker Corporation $SYK Shares Sold by Pacer Advisors Inc.
- Published
- 7 Aug 2026 02:08
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
04
2026
GuruFocusArchivedNeutral tone
Is It Too Late to Buy Stryker Corp (SYK) After 4.8% Rally? GF Va
- Published
- 4 Aug 2026 11:38
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Aug
02
2026
simplywall.stArchivedNeutral tone
Stryker (SYK) Could Be 16% Below Fair Value On Its Latest Results
- Published
- 2 Aug 2026 13:10
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
31
2026
TradingViewArchivedNeutral tone
Stryker Corporation Stock 12‑Month Price Target Cut to $386.36, Implies 11% Upside
- Published
- 31 Jul 2026 15:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
30
2026
MarketBeatArchivedNeutral tone
Stryker (NYSE:SYK) Raised to Strong-Buy at UBS Group
- Published
- 30 Jul 2026 05:47
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
28
2026
Traders UnionArchivedPositive tone
Stryker stock gains 2.02 percent as StrykerEndo promotes fast repairs and trusted service
- Published
- 28 Jul 2026 11:37
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
27
2026
Market sourceArchivedPositive tone
Exploring Analyst Estimates for Stryker (SYK) Q2 Earnings, Beyond Revenue and EPS
- Published
- 27 Jul 2026 16:25
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
24
2026
GuruFocusArchivedNeutral tone
Stryker Corp (SYK) Shares Surge 3.1% -- What GF Score of 92 Tells Investors
- Published
- 24 Jul 2026 04:27
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
22
2026
GuruFocusArchivedNeutral tone
Stryker (SYK) Offers Attractive Valuations Amid Market Shifts
- Published
- 22 Jul 2026 17:07
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
20
2026
Market sourceArchivedNeutral tone
Stryker (SYK) Stock Looks Cheap On Cash Flow But Fair On Earnings
- Published
- 20 Jul 2026 18:13
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
17
2026
TradingKeyArchivedNeutral tone
Stryker Corp Stock (SYK) Moved Down by 3.42% on Jul 17: A Full Analysis
- Published
- 17 Jul 2026 18:33
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
15
2026
simplywall.stArchivedNeutral tone
Can Stryker (SYK) Turn Nerve Repair Biomaterials Into a Core Neurotechnology Growth Engine?
- Published
- 15 Jul 2026 20:57
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
12
2026
The Globe and MailArchivedNeutral tone
Wells Fargo Remains a Buy on Stryker (SYK)
- Published
- 12 Jul 2026 04:17
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
10
2026
timothysykes.comArchivedNeutral tone
Stryker Corporation (SYK) Stock Price | Live Quotes & Charts | NYSE
- Published
- 10 Jul 2026 12:42
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
08
2026
simplywall.stArchivedNeutral tone
Stryker (SYK) And The Valuation Case Following Fresh Mako Robotics Enthusiasm
- Published
- 8 Jul 2026 12:17
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
07
2026
ChartMillArchivedNeutral tone
Stryker Corp (NYSE:SYK): A High-Grade Dividend Stock for Sustainable Income
- Published
- 7 Jul 2026 11:50
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
06
2026
simplywall.stArchivedNeutral tone
Russell Growth Index Exit Could Be A Game Changer For Stryker’s (SYK) Investor Base
- Published
- 6 Jul 2026 16:21
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
02
2026
TradingViewArchivedNeutral tone
Enterprise value to revenue forward of Stryker Corporation – FWB:SYK
- Published
- 2 Jul 2026 17:10
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jul
02
2026
Seeking AlphaArchivedNeutral tone
Stryker Stock: The Reshaped Product Portfolio Will Drive Growth (NYSE:SYK)
- Published
- 2 Jul 2026 10:34
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
29
2026
marketscreener.comArchivedNeutral tone
Stryker Corporation(NYSE: SYK) dropped from Russell 3000E Growth Benchmark
- Published
- 29 Jun 2026 08:51
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
28
2026
GuruFocusArchivedNeutral tone
Stryker Corp (SYK) Shares Surge 5.2% -- What GF Score of 92 Tells Investors
- Published
- 28 Jun 2026 06:16
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
26
2026
Insider MonkeyArchivedNeutral tone
What Makes Stryker Corp. (SYK) One of the Best Robotics and Automation Stocks
- Published
- 26 Jun 2026 05:50
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
25
2026
Stock TitanArchivedNeutral tone
Stryker enlists Shane Lowry to spotlight joint pain caregivers
- Published
- 25 Jun 2026 07:03
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
23
2026
Insider MonkeyArchivedNeutral tone
BofA Cuts Stryker (SYK) Target; Is a Medtech Slowdown Starting to Show?
- Published
- 23 Jun 2026 02:30
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
Jun
21
2026
Insider MonkeyArchivedNeutral tone
Jim Cramer Says Stryker and Its Orthopedic Peers Are Facing a Real Tough Run
- Published
- 21 Jun 2026 07:43
- Catalyst
- Historical snapshot
- Coverage
- Direct company
- Duplicates
- 1 consolidated
How the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean a balanced tape or that direction has been withheld for insufficient evidence; the status label distinguishes them.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
The page describes completed evidence available at the stated time. It is research context, not a forecast, recommendation, target or execution instruction.